세계 암 분야 AI 시장 규모는 2024년 22억 달러에서 예측 기간 동안 23.1%의 CAGR(연평균 성장률)을 기록하며 2029년에는 63억 달러 규모에 달할 것으로 예상됩니다.
북미 시장은 2024년 9억 9,560만 달러에서 21.6%의 CAGR로 2029년에는 27억 달러에 달할 것으로 예상됩니다. 아시아태평양 시장은 2024년 4억 7,650만 달러에서 26.2%의 CAGR로 2029년 15억 달러에 달할 것으로 예상됩니다.
세계 암 분야 AI 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 규제 환경, 신기술 및 기술 개발 동향, 시장 규모 추정 및 예측, 각종 부문별·지역별 상세 분석, 경쟁 상황, 주요 기업 프로파일 등의 정보를 전해드립니다.
목차
제1장 주요 요약
시장 전망
조사 범위
시장 분석
제2장 시장 개요
개요
암 분야 AI의 현재 응용과 향후 응용
진단
치료
스크리닝과 조기 발견
의약품 발견과 개발
제3장 시장 역학
시장 역학 현황
시장 성장 촉진요인
의약품 발견과 개발의 AI
암 발생률 증가
시장 성장 억제요인
데이터 수집과 프라이버시
오감지와 바이어스
시장 기회
AI 대응 하드웨어 제품
제4장 신기술
다발암성 질환 조기 발견을 위한 AI
테라노스틱스와 AI
생성형 AI 툴
연합 학습
제5장 시장 세분화 분석
세분화 내역
시장 분석 : 암 유형별
유방암
폐암
전립선암
소화기암
뇌종양
기타
시장 분석 : 용도별
진단
의약품 발견과 개발
치료
암검진
기타
시장 분석 : 최종사용자별
시장 규모와 예측
병원
진단 센터
제약회사
조사기관
지역적 내역
시장 분석 : 지역별
시장 규모와 예측
북미
유럽
아시아태평양
기타 지역
제6장 경쟁 정보
개요
파트너십
M&A 활동
투자와 자금 조달
특허 분석
제7장 암 분야 AI : 지속가능성
암 분야 AI : 지속가능성
ESG 데이터 이해
환경 퍼포먼스
사회적 퍼포먼스
거버넌스 퍼포먼스
BCC의 결론
제8장 부록
조사 방법
정보 출처
약어
기업 개요
AZRA AI
CONCERTAI
GE HEALTHCARE
ICAD INC.
LUNIT INC.
MEDIAN TECHNOLOGIES
NVIDIA CORP.
QUEST DIAGNOSTICS INC.
SIEMENS HEALTHINEERS AG
ksm
영문 목차
영문목차
The global market for artificial intelligence (AI) in cancer is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth rate (CAGR) of 23.1% from 2024 through 2029.
The North American market for AI in cancer is estimated to increase from $995.6 million in 2024 to reach $2.7 billion by 2029, at a CAGR of 21.6% from 2024 through 2029.
The Asia-Pacific market for AI in cancer is estimated to increase from $476.5 million in 2024 to reach $1.5 billion by 2029, at a CAGR of 26.2% from 2024 through 2029.
Report Scope:
The report highlights AI technology's current and future market potential for cancer applications. It provides a detailed analysis of the market drivers, restraints and opportunities. The report also covers market projections through 2029 and presents a competitive environment and product analysis. The report provides market estimates and forecasts based on application, cancer type and region. By application type, the market is segmented into cancer screening, diagnosis, therapy, drug discovery and development and others. By cancer type, the market is segmented into breast, lung, prostate, gastrointestinal, brain and others. By end user, the market is segmented into hospitals, diagnostic centers, pharmaceutical companies and research institutions. The report includes profiles of the key companies with detailed information about their business segments, financials, product portfolios and recent developments.
By geographical region, the market is segregated into North America, Europe, Asia Pacific and the Rest of the world. The North American region includes countries the U.S., Canada and Mexico. Europe includes Germany, the U.K., Italy, France, Spain and the Rest of Europe; Asia-Pacific includes China, Japan, India, South Korea, Australia and the Rest of Asia-Pacific. For market estimates, data is provided for 2021 and 2022 as the historic years, 2023 as the base year and 2029 as the forecast year.
Report Includes:
42 data tables and 44 additional tables
An up-to-date overview of the global markets for artificial intelligence (AI) in cancer
Analysis of the global market trends, with data from 2021-2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2029
Evaluation of the size of the market for artificial intelligence (AI) in cancer and revenue growth prospects, accompanied by a market share analysis by type, application, end user and region
Assessment of market dynamics such as drivers, restraints and opportunities
Coverage of current and emerging applications of AI in cancer and information on theranostics and generative AI tools
A discussion on ESG challenges and practices in the industry
Assessment of the vendor landscape, including the market shares of key companies, their product portfolios and financial overviews
Information on recent mergers, acquisitions, expansions, collaborations, investments, divestments, product launches, and other strategic developments
Company profiles of major players within the industry, including Siemens Healthineers, GE Healthcare, NVIDIA Corp., and Lunit Inc.
Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Insights
Chapter 2 Market Overview
Overview
Current and Emerging Applications of AI in Cancer
Diagnosis
Therapy
Screening and Early Detection
Drug Discovery and Development
Chapter 3 Market Dynamics
Market Dynamics Snapshot
Market Drivers
AI in Drug Discovery and Development
Increasing Incidence of Cancer
Market Restraints
Data Collection and Privacy
False Positives and Bias
Market Opportunities
AI-Enabled Hardware Products
Chapter 4 Emerging Technologies
Introduction
AI for Multi-Cancer Early Detection
Theranostics and AI
Generative AI Tools
Federated Learning
Chapter 5 Market Segmentation Analysis
Segmentation Breakdown
Market Analysis by Cancer Type
Breast Cancer
Lung Cancer
Prostate Cancer
Gastrointestinal Cancer
Brain Cancer
Other Cancers
Market Analysis by Application
Diagnosis
Drug Discovery and Development
Therapy
Cancer Screening
Other Applications
Market Analysis by End User
Market Size and Forecast
Hospitals
Diagnostic Centers
Pharmaceutical Companies
Research Institutions
Geographic Breakdown
Market Analysis by Region
Market Size and Forecast
North America
Europe
Asia-Pacific
Rest of the World
Chapter 6 Competitive Intelligence
Overview
Partnerships
M&A Activities
Investments and Funding
Patent Analysis
Chapter 7 Sustainability in the AI in the Cancer Market
